Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 27 contracts
Sources: Security Agreement (Theriva Biologics, Inc.), Common Stock Purchase Warrant (Theriva Biologics, Inc.), Common Stock Purchase Warrant (Theriva Biologics, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, provided however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 19 contracts
Sources: Warrant Agreement (Adial Pharmaceuticals, Inc.), Series D Common Stock Purchase Warrant (Adial Pharmaceuticals, Inc.), Warrant Agreement (Adial Pharmaceuticals, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement in this Section 3(f) by filing such notice information with the Commission on its Electronic Data Gathering, Analysis, and Retrieval (▇▇▇▇▇) system pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 17 contracts
Sources: Common Stock Purchase Warrant (PMGC Holdings Inc.), Warrant Agreement (60 Degrees Pharmaceuticals, Inc.), Placement Agent Common Stock Purchase Warrant (60 Degrees Pharmaceuticals, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f3(g) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 16 contracts
Sources: Security Agreement (Healthcare Triangle, Inc.), Security Agreement (Healthcare Triangle, Inc.), Common Stock Purchase Warrant (bioAffinity Technologies, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission SEC pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 7 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Glucotrack, Inc.), Pre Funded Common Stock Purchase Warrant (Hepion Pharmaceuticals, Inc.), Pre Funded Common Stock Purchase Warrant (Algorhythm Holdings, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement in this Section 3(f) by filing such notice information with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 7 contracts
Sources: Warrant Agreement (ShiftPixy, Inc.), Common Stock Purchase Warrant (ShiftPixy, Inc.), Common Stock Purchase Warrant (Virpax Pharmaceuticals, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver mail or email to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement set forth in this Section 3(f3(g) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 6 contracts
Sources: Representative’s Warrant Agreement (Perfect Moment Ltd.), Underwriting Agreement (Perfect Moment Ltd.), Common Stock Purchase Warrant (Perfect Moment Ltd.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 6 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Allarity Therapeutics, Inc.), Pre Funded Common Stock Purchase Warrant (Shuttle Pharmaceuticals Holdings, Inc.), Pre Funded Common Stock Purchase Warrant (Entero Therapeutics, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 5 contracts
Sources: Security Agreement (iBio, Inc.), Security Agreement (iBio, Inc.), Security Agreement (iBio, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, provided however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 5 contracts
Sources: Common Stock Purchase Warrant (Klotho Neurosciences, Inc.), Placement Agent Purchase Warrant (Safe & Green Development Corp), Common Stock Purchase Warrant (Safe & Green Development Corp)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; adjustment provided, however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 5 contracts
Sources: Placement Agreement (Cadrenal Therapeutics, Inc.), Security Agreement (Cadrenal Therapeutics, Inc.), Placement Agent Common Stock Agreement (Cadrenal Therapeutics, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares ADSs or Exchange Warrants and setting forth a brief statement of the facts requiring such adjustment; provided, however, however that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its E▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 4 contracts
Sources: Security Agreement (Quoin Pharmaceuticals, Ltd.), Security Agreement (Quoin Pharmaceuticals, Ltd.), Security Agreement (Quoin Pharmaceuticals, Ltd.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver mail or email to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f3(g) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 4 contracts
Sources: Representative’s Warrant Agreement (Forza X1, Inc.), Underwriting Agreement (Twin Vee PowerCats, Co.), Underwriting Agreement (Forza X1, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 32, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 3 contracts
Sources: Security Agreement (iBio, Inc.), Security Agreement (iBio, Inc.), Settlement Agreement (iBio, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, ; provided however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 3 contracts
Sources: Common Stock Purchase Warrant (Scorpius Holdings, Inc.), Common Stock Purchase Warrant (Scorpius Holdings, Inc.), Common Stock Purchase Warrant (Scorpius Holdings, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement in this Section 3(f) by filing such notice information with the Commission on its E▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 2 contracts
Sources: Share Purchase Agreement (Qualigen Therapeutics, Inc.), Pre Funded Warrant Agreement (Qualigen Therapeutics, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver mail to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement in this Section 3(f3(c) by filing such notice information with the Commission on its E▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 2 contracts
Sources: Security Agreement (Zerospo), Subscription Agreement (PishPosh, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Q, Annual Report on Form 10-K.K or in a press release.
Appears in 2 contracts
Sources: Pre Funded Common Stock Purchase Warrant (Virpax Pharmaceuticals, Inc.), Pre Funded Common Stock Purchase Warrant (Virpax Pharmaceuticals, Inc.)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement in this Section 3(f3(g) by filing such notice with the Commission pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 1 contract
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; adjustment provided, however, that the Company may satisfy this the notice requirement in this Section 3(f3(h) by filing such notice information with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 1 contract
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a written notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this notice requirement with respect to the Holder in this Section 3(f3(h) by filing such notice information with the Commission on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 1 contract
Sources: Warrant Agreement (Biolase, Inc)
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares ADSs and setting forth a brief statement of the facts requiring such adjustment; provided, however, however that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission on its E▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 1 contract
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that no notice shall be required if the information is disseminated by the Company may satisfy this notice requirement in this Section 3(f) by a filing such notice with the Commission SEC on its ▇▇▇▇▇ system pursuant to a Current Report on Form 8-K, K or Quarterly Report on Form 10-Q or Annual Report on Form 10-K.K or in a press release.
Appears in 1 contract
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the Company may satisfy this the notice requirement in this Section 3(f) by filing such notice information with the Commission on its E▇▇▇▇ system pursuant to a Current Report on Form 8-K, Quarterly Report on Form 10-Q or Annual Report on Form 10-K.
Appears in 1 contract
Sources: Common Share Purchase Warrant (BriaCell Therapeutics Corp.)